Suchergebnisse - "Knapper, Steven"

PubPharm (41)

1

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Russell, N. | Wilhelm-Benartzi, C. | Othman, J. | +117

2

Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML

enthalten in: Blood advances | 2024

von Jimenez-Chillon, C. | Othman, J. | Taussig, D. | +29

3

Tamoxifen for the treatment of myeloproliferative neoplasms : A Phase II clinical trial and exploratory analysis

enthalten in: Nature communications | 2023

von Fang, Z. | Corbizi Fattori, G. | McKerrell, T. | +33

4

Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML : the UK NCRI AML18 trial

enthalten in: Blood | 2023

von Freeman, S. | Thomas, A. | Thomas, I. | +19

CommentIn: Blood. 2023 Nov 16;142(20):1673-1674. - PMID 37971761

5

FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML

enthalten in: Leukemia | 2023

von Othman, J. | Potter, N. | Mokretar, K. | +35

6

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Harrison, C. | Nangalia, J. | Boucher, R. | +30

7

A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia : Results from the LI-1 trial

enthalten in: British journal of haematology | 2023

von Mussai, F. | De Santo, C. | Cheng, P. | +13

8

Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patients

enthalten in: Blood advances | 2021

von Dennis, M. | Thomas, I. | Ariti, C. | +11

9

Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm

enthalten in: Leukemia | 2021

von Salisbury, R. | Curto-Garcia, N. | O'Sullivan, J. | +34

10

Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivo

enthalten in: British journal of haematology | 2021

von Rastogi, N. | Baker, S. | Man, S. | +8

1
2
3
4
5
Nächster »
[5]